Jonathan Wolleben Reiterated (BCRX) at Buy and Held Target at $16 on, Feb 22nd, 2023

Show Stocks and Investing Publications

Wed, February 22, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Edward Nash Maintained (TVTX) at Strong Buy with Increased Target to $44 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Jim Sanderson Downgraded (TXRH) to Hold on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Ariel Rosa Maintained (UPS) at Buy and Held Target at $206 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Deepak Mathivanan Reiterated (UBER) at Buy and Held Target at $45 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Bora Lee Maintained (UNIT) at Hold with Decreased Target to $7 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Allison Poliniak Cusic Maintained (TRN) at Buy with Decreased Target to $30 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Justin Long Maintained (TRN) at Hold with Decreased Target to $26 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Scott Fidel Maintained (THC) at Hold with Increased Target to $64 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Simeon Siegel Maintained (TJX) at Buy and Held Target at $85 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Keith Hughes Downgraded (TILE) to Hold and Decreased Target to $9 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Bill Katz Reiterated (TPG) at Hold and Held Target at $36 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Tate Sullivan Upgraded (TOPS) to Strong Buy and Held Target at $30 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Jay McCanless Maintained (TPH) at Buy with Increased Target to $27 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Steven Cahall Maintained (AMCX) at Sell with Increased Target to $15 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Ed Arce Maintained (AKBA) at Hold and Held Target at $1.25 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

John Heagerty Downgraded (AIG) to Hold and Decreased Target to $65 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Kevin Mcveigh Maintained (ALIT) at Buy with Increased Target to $16 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Kyle Peterson Maintained (ALIT) at Strong Buy with Increased Target to $13 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Chris Carey Maintained (TAP) at Sell with Increased Target to $48 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Kaumil Gajrawala Maintained (TAP) at Sell with Increased Target to $49 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Christopher Horvers Maintained (TGT) at Buy with Increased Target to $205 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Jeanine Wai Maintained (STR) at Buy with Decreased Target to $30 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Josh Beck Maintained (SQ) at Buy with Increased Target to $100 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Stephen Byrd Maintained (SRE) at Hold with Decreased Target to $79 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

David Hynes Maintained (SPT) at Strong Buy with Increased Target to $70 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Scott Berg Reiterated (SPT) at Strong Buy and Held Target at $75 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Raimo Lenschow Maintained (SPT) at Buy with Increased Target to $72 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Clarke Jeffries Maintained (SPT) at Buy with Increased Target to $78 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Tavy Rosner Maintained (SPNS) at Hold with Increased Target to $24 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Kevin Kumar Maintained (SPNS) at Strong Buy with Decreased Target to $26 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Mayank Tandon Maintained (SPNS) at Strong Buy with Increased Target to $24 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

George Sellers Reiterated (STAA) at Buy and Held Target at $85 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

David Saxon Maintained (STAA) at Strong Buy with Decreased Target to $78 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Ronald Kamdem Maintained (SPG) at Buy with Increased Target to $132 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Stephen Byrd Maintained (SO) at Sell with Decreased Target to $61 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Jonathan Yon Maintained (SLQT) at Hold with Increased Target to $3 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

William Thompson Maintained (SM) at Sell with Decreased Target to $32 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Stephen Byrd Maintained (CMS) at Hold with Decreased Target to $63 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Stephen Byrd Maintained (CNP) at Buy with Decreased Target to $30 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Stephen Byrd Maintained (CEG) at Buy with Decreased Target to $101 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Ross Fowler Maintained (CEG) at Strong Buy with Decreased Target to $108 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Nicholas Campanella Downgraded (CEG) to Hold and Decreased Target to $83 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Benjamin Theurer Maintained (BRFS) at Hold with Decreased Target to $1.5 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Adrienne Yih Maintained (BBWI) at Hold with Increased Target to $43 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Jonathan Wolleben Reiterated (BCRX) at Buy and Held Target at $16 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Serge Belanger Upgraded (BCRX) to Strong Buy and Held Target at $14 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Andrew Fein Reiterated (BCRX) at Strong Buy and Held Target at $30 on, Feb 22nd, 2023

[ Wed, Feb 22nd 2023 ]: WOPRAI

Steven Seedhouse Maintained (APLS) at Strong Buy with Increased Target to $139 on, Feb 22nd, 2023

Jonathan Wolleben Reiterated (BCRX) at Buy and Held Target at $16 on, Feb 22nd, 2023

//stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-16-on-feb-22nd-2023.html

Published in Stocks and Investing on Monday, October 28th 2024 at 1:47 GMT by WOPRAI

🞛 This publication is a summary or evaluation of another publication

Jonathan Wolleben of JMP Securities, Reiterated "BioCryst Pharmaceuticals, Inc." (BCRX) at Buy and Held Target at $16 on, Feb 22nd, 2023.

Jonathan has made no other calls on BCRX in the last 4 months.

There are 2 other peers that have a rating on BCRX. Out of the 2 peers that are also analyzing BCRX, 1 agrees with Jonathan's Rating of Hold. Following is the relevant analyst calls for the last 4 months

Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $13 on, Wednesday, November 2nd, 2022

This is the rating of the analyst that currently disagrees with Jonathan

Liisa Bayko of "Evercore ISI Group" Upgraded from Hold to Buy and Held Target at $16 on, Wednesday, November 2nd, 2022